Rational engineering of recombinant modified vaccinia virus Ankara to enhance both innate and adaptive immunity for cancer immunotherapy

被引：0

作者：

Yang, N. ^{[3
]}

Wang, Y. ^{[3
]}

Liu, S. ^{[3
]}

Luna, J. ^{[1
]}

Rossi, A. ^{[3
]}

Mazo, G. ^{[3
]}

Tan, A. ^{[2
]}

Wang, J. ^{[4
]}

Yan, W. ^{[5
]}

Choi, J. ^{[5
]}

Xiang, J. ^{[2
]}

Rice, C. ^{[1
]}

Merghoub, T. ^{[3
]}

Wolchok, J. ^{[3
]}

Deng, L. ^{[3
]}

机构：

[1] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA

[2] Weill Cornell Med, New York, NY USA

[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[4] Genvira Biosci, Ottawa, ON, Canada

[5] IMVAQ Therapeut, Sammamish, WA USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2021年 / 141卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

697

引用

页码：S121 / S121

页数：1

共 50 条

[11] Recombinant Strains of Oncolytic Vaccinia Virus for Cancer Immunotherapy
Yasmin Shakiba
Pavel O. Vorobyev
Marah Mahmoud
Azzam Hamad
Dmitriy V. Kochetkov
Gaukhar M. Yusubalieva
Vladimir P. Baklaushev
Peter M. Chumakov
Anastasia V. Lipatova
Biochemistry (Moscow), 2023, 88 : 823 - 841
[12] Recombinant Strains of Oncolytic Vaccinia Virus for Cancer Immunotherapy
Shakiba, Yasmin
Vorobyev, Pavel O. O.
Mahmoud, Marah
Hamad, Azzam
Kochetkov, Dmitriy V. V.
Yusubalieva, Gaukhar M. M.
Baklaushev, Vladimir P. P.
Chumakov, Peter M. M.
Lipatova, Anastasia V. V.
BIOCHEMISTRY-MOSCOW, 2023, 88 (06) : 823 - 841
[13] Modified Vaccinia Virus Ankara Encoding Influenza Virus Hemagglutinin Induces Heterosubtypic Immunity in Macaques
Florek, Kelsey R.
Weinfurter, Jason T.
Jegaskanda, Sinthujan
Brewoo, Joseph N.
Powell, Tim D.
Young, Ginger R.
Das, Subash C.
Hatta, Masato
Broman, Karl W.
Hungnes, Olav
Dudman, Susanne G.
Kawaoka, Yoshihiro
Kent, Stephen J.
Stinchcomb, Dan T.
Osorio, Jorge E.
Friedrich, Thomas C.
JOURNAL OF VIROLOGY, 2014, 88 (22) : 13418 - 13428
[14] Cell-Mediated Immunity Induced by two Recombinant Modified Vaccinia Virus Ankara Vaccines Delivering the G Antigen of Nipah Virus
Kalodimou, G.
Veit, S.
Jany, S.
Luelf-Averhoff, A. T.
Sutter, G.
Volz, A.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 129 - 129
[15] Transient host range selection for genetic engineering of modified vaccinia virus Ankara
Staib, C
Drexler, I
Ohlmann, M
Wintersperger, S
Erfle, V
Sutter, G
BIOTECHNIQUES, 2000, 28 (06) : 1137 - +
[16] Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy
Verdeil, Gregory
Marquardt, Kristi
Surh, Charles D.
Sherman, Linda A.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (43) : 16683 - 16688
[17] Immune checkpoint inhibitors enhance benefits of modified vaccinia virus Ankara to improve survival in preclinical models of cancer
Rittner, Karola
Remy-Ziller, Christelle
Hortelano, Julie
Farine, Isabelle
de Meyer, Micael
Nourtier, Virginie
Gantzer, Murielle
Thioudellet, Christine
Slos, Philippe
Preville, Xavier
CANCER RESEARCH, 2015, 75
[18] Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice
Bohnen, C.
Wangorsch, A.
Schuelke, S.
Nakajima-Adachi, H.
Hachimura, S.
Burggraf, M.
Suezer, Y.
Schwantes, A.
Sutter, G.
Waibler, Z.
Reese, G.
Toda, M.
Scheurer, S.
Vieths, S.
ALLERGY, 2013, 68 (08) : 1021 - 1028
[19] Skin scarification with modified vaccinia ankara (MVA) virus generates protective pulmonary immunity
Pan, Y.
Tian, T.
Park, C.
Stingley, C.
de Masson, A.
Kupper, T.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S10 - S10
[20] Trovax, a recombinant modified vaccinia ankara virus encoding 5T4
Kim, Dae Won
Krishnamurthy, Vikram
Bines, Steven D.
Kaufman, Howard L.
HUMAN VACCINES, 2010, 6 (10): : 784 - 791

← 1 2 3 4 5 →